Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of Sandostatin LAR for prevention of chemoradiotherapy-induced diarrhea in preoperative rectal cancer
2005-003784-23Phase 2Completed
- Sponsor
- UZ Leuven
- Start
- Jan 2006
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, open-label trial of octreotide in diarrhea (2 arms), sponsored by UZ Leuven. Primary endpoints: Primary efficacy endpoint and Dose comparison endpoint. Started Jan 2006; status: completed.
02
Drugs
octreotide
03
Conditions
diarrhea
Beyond the preview
Go deeper on 2005-003784-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003784-23.